Device Classification Name |
Glucose Dehydrogenase, Glucose
|
510(k) Number |
K111268 |
Device Name |
CONTOUR (R) NEXT BLOOD GLUCOSE MONITORING SYSTEM |
Applicant |
BAYER HEALTHCARE |
430 SOUTH BEIGER STREET |
MISHAWAKA,
IN
46544
|
|
Applicant Contact |
WEIPING ZHONG |
Correspondent |
BAYER HEALTHCARE |
430 SOUTH BEIGER STREET |
MISHAWAKA,
IN
46544
|
|
Correspondent Contact |
WEIPING ZHONG |
Regulation Number | 862.1345
|
Classification Product Code |
|
Subsequent Product Codes |
|
Date Received | 05/04/2011 |
Decision Date | 03/06/2012 |
Decision |
Substantially Equivalent
(SESE) |
Regulation Medical Specialty |
Clinical Chemistry
|
510k Review Panel |
Clinical Chemistry
|
Summary |
Summary
|
FDA Review |
Decision Summary
|
Type |
Traditional
|
Clinical Trials |
NCT01264016
|
Reviewed by Third Party |
No
|
Combination Product |
No
|
Recalls |
CDRH Recalls
|
|
|